Search Results 711-720 of 17103 for cognitive behavioral therapy

  1. Alzheimer's disease - Doctors and departments - Mayo Clinic

    Behavioral Neurology · Neurology · Physical Medicine ... Researchers at Mayo Clinic study Alzheimer's disease, mild cognitive impairment, and other conditions ...

  2. Alzheimer's Disease Clinical Trials

    ... Cognitive Composite 5 (PACC5) at 216 weeks of treatment. ... Behavioral Function® (NIHTB) for use in studies ... therapy. Advanced Care Planning in ...

  3. Alzheimer's Disease Clinical Trials - Mayo Clinic Research

    ... Cognitive Composite 5 (PACC5) at 216 weeks of treatment. ... Behavioral Function® (NIHTB) for use in studies ... therapy. Advanced Care Planning in ...

  4. Hugo Botha, M.B., Ch.B. - Doctors and Medical Staff - Mayo Clinic

    Alzheimer's Disease Treatment Clinic · Behavioral Neurology ... Mild cognitive impairment; Normal pressure ... MemberInternational Society to Advance Alzheimer's ...

  5. Neurology - Clinical trials - Mayo Clinic

    ... cognitive (such as learning and memory) deterioration after WBRT. Memantine hydrochloride may enhance cognitive function by binding to and inhibiting ...

  6. Overview - Movement Neurophysiology Laboratory - Mayo Clinic Research

    With the hope of advancing new treatments and controlling cognitive decline in Parkinson's disease and related conditions, Dr. Caviness and his team are ...

  7. Preclinical research shows senescent cell removal improves cognitive function - Mayo Clinic News Network

    ... therapy for age-related cognitive impairment in patients. This finding also reinforced a 2018 Nature paper by Mayo Clinic authors which showed that ...

  8. Neurology - Clinical trials

    Whole brain radiotherapy (WBRT) is the most common treatment for brain metastasis. Unfortunately, the majority of patients with brain metastases experience ...

  9. Clinical trials - Oncology (Medical)

    ... cognitive function in post-menopausal Breast Cancer Survivors (BCS). A Study to Compare Optimal MRI Timing for Pre-surgical Planning to LINAC-based Therapy.

  10. Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD) - Mayo Clinic

    The purpose of this study is to demonstrate the safety and efficacy of TRx0237 in the treatment of patients with behavioral variant frontotemporal dementia ( ...